Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

COPD is a known risk factor for PE. To estimate how the obstructive lung disease may contribute to PE-related deaths among ...

reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process. ICER isn't officially involved in the price negotiations introduced ...

Every medication, regardless of its intended use, comes with some risks. Unfortunately, they aren't always apparent right away. In some cases, doctors only learn about the risks of some medications ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

The FDA has cleared the start of clinical trial testing of KT-621, an experimental oral medication for COPD and other ...

Exploring Chronic obstructive pulmonary disease (COPD), this infographic highlights the global incidence, current management ...

You can lower your COPD risk at any age by quitting smoking, avoiding lung irritants, and managing symptoms early. Protect ...

An adverse reaction is an undesirable reaction to a medication that's been taken correctly. It may occur immediately, hours, or years after starting a drug. Reactions might include minor side effects ...